Caio Cesar Barbosa Bomfim

5PUBLICATIONS
44CO-AUTHORS
Tissue engineeringMolecular targetsHaematological tumoursInnate immunityMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 11, 2026
Dual human lung models reveal compartment-specific activity of anti-tuberculosis drugs and host-directed therapies.

|Nov 28, 2025
Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Claire Delehouzé, Melodie Mallais, Arnaud Comte

|Dec 08, 2023
BACH1 promotes tissue necrosis and Mycobacterium tuberculosis susceptibility.

Eduardo P Amaral, Sivaranjani Namasivayam, Artur T L Queiroz

|May 22, 2023
TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms.

Jammy Mariotton, Emmanuel Cohen, Aiwei Zhu

|Sep 07, 2022
GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection.

Eduardo P Amaral, Taylor W Foreman, Sivaranjani Namasivayam

Pageof 1

Frequent Collaborators

2 joint publications

Daniel L Barber

2 joint publications

Marcelo Cordeiro-Santos

2 joint publications

Katrin D Mayer-Barber

2 joint publications

Eduardo P Amaral